Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Next Frontier Capital is an early-stage venture capital firm managing over $250M across four funds. They invest in 20-25 startups, focusing on mission-driven entrepreneurs in the US, particularly the Rocky Mountain region. They have made 58 investments and achieved 9 exits to date, with their latest Fund IV closing at $102M in 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Next Frontier Capital.